The first Biolife Solutions trade was made in Q1 2015.
Since then Ken Griffin bought shares 33 more times and sold shares on 35 occasions. The investor completely sold their stake between Q2 2025 and Q2 2025.
Avg closing price
Price range
Increased shares by 242.2% (+297k shares)
Q2 2025
Avg closing price
$22.49
Price range
$20.64
-
$25.27
Sold 57.6% shares (-167k shares)
Q1 2025
Avg closing price
$26.37
Price range
$22.84
-
$28.49
Increased shares by 9.1% (+24.1k shares)
Q4 2024
Avg closing price
$25.01
Price range
$20.47
-
$27.52
Increased shares by 171.4% (+168k shares)
Q3 2024
Avg closing price
$23.60
Price range
$19.19
-
$26.52
Sold 82.6% shares (-464k shares)
Q2 2024
Avg closing price
$19.41
Price range
$15.14
-
$22.99
Increased shares by 1.1% (+6.09k shares)
Q1 2024
Avg closing price
$17.49
Price range
$15.35
-
$18.82
Sold 8.7% shares (-53k shares)
Q4 2023
Avg closing price
$12.76
Price range
$8.99
-
$16.86
Increased shares by 347878.9% (+609k shares)
Q3 2023
Avg closing price
$15.76
Price range
$10.81
-
$22.96
Sold 99.4% shares (-31.3k shares)
Q2 2023
Avg closing price
$21.06
Price range
$17.19
-
$24.34
Sold 38.9% shares (-20k shares)
Q1 2023
Avg closing price
$22.49
Price range
$17.67
-
$26.07
Increased shares by 150.4% (+31k shares)
Q4 2022
Avg closing price
$20.65
Price range
$16.95
-
$25.07
Sold 67.7% shares (-43.3k shares)
Q3 2022
Avg closing price
$21.40
Price range
$14.64
-
$26.70
Sold 52.3% shares (-70k shares)
Q2 2022
Avg closing price
$14.67
Price range
$10.54
-
$24.20
Increased shares by 22.6% (+24.7k shares)
Q1 2022
Avg closing price
$26.33
Price range
$20.81
-
$37.29
Increased shares by 133.4% (+62.4k shares)
Q4 2021